Antrodin C inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via suppression of Smad2/3 and β-catenin signaling pathways

PLoS ONE

Volumn 10, Issue 2, 2015, Pages

  Kumar, K J Senthil ^a   Vani, M Gokila ^a   Chueh, Pin Ju ^a,b   Mau, Jeng Leun ^a   Wang, Sheng Yang ^a,c  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b ASIA UNIVERSITY   (Taiwan)

^c AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTRODIN C; BETA CATENIN; GELATINASE A; GELATINASE B; MALEIMIDE DERIVATIVE; NERVE CELL ADHESION MOLECULE; OCCLUDIN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG; UROKINASE; UVOMORULIN; VIMENTIN; ANTINEOPLASTIC AGENT; CADHERIN;

ACTIN FILAMENT; ANTINEOPLASTIC ACTIVITY; ANTRODIA CINNAMOMEA; ARTICLE; BREAST METASTASIS; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MCF 7 CELL LINE; PHENOTYPE; SIGNAL TRANSDUCTION; UPREGULATION; ANTRODIA; BREAST TUMOR; CELL MOTION; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; FEMALE; ISOLATION AND PURIFICATION; MCF-7 CELL LINE; METABOLISM; PATHOLOGY;

ANTRODIA CINNAMOMEA;

ACTIN CYTOSKELETON; ANTINEOPLASTIC AGENTS; ANTRODIA; BREAST NEOPLASMS; CADHERINS; CELL MOVEMENT; CELL SURVIVAL; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; MALEIMIDES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MCF-7 CELLS; SIGNAL TRANSDUCTION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UP-REGULATION;

EID: 84922572428     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0117111     Document Type: Article

References (33)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90. doi: 10.3322/caac.20107 PMID: 21296855
2. Scully OJ, Bay BH, Yip G, Yu Y (2012) Breast cancer metastasis. Cancer Genomics Proteomics 9: 311-320. PMID: 22990110
3. Tsai JH, Yang J (2013) Epithelial-mesenchymal plasticity in carcinoma metastasis. Genes Dev 27: 2192-2206. doi: 10.1101/gad.225334.113 PMID: 24142872
4. Yao D, Dai C, Peng S (2011) Mechanism of the mesenchymal-epithelial transition and its relationship with metastatic tumor formation. Mol Cancer Res 9: 1608-1620. doi: 10.1158/1541-7786.MCR-10-0568 PMID: 21840933
5. Thiery JP, Sleeman JP (2006) Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 7: 131-142. PMID: 16493418
6. Mazzone M, Comoglio PM (2006) The Met pathway: master switch and drug target in cancer progression. FASEB J 20: 1611-1621. PMID: 16873884
7. Zarzynska JM (2014) Two FACes of TGF-beta1 in breast cancer. Mediators Inflamm 2014: 141747. doi: 10.1155/2014/141747 PMID: 24891760
8. Lv ZD, Kong B, Li JG, Qu HL, Wang XG, et al. (2013) Transforming growth factor-beta 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition. Oncol Rep 29: 219-225. doi: 10.3892/or.2012.2111 PMID: 23129177
9. Moustakas A, Souchelnytskyi S, Heldin CH (2001) Smad regulation in TGF-beta signal transduction. J Cell Sci 114: 4359-4369. PMID: 11792802
10. Javelaud D, Alexaki VI, Dennler S, Mohammad KS, Guise TA, et al. (2011) TGF-beta/SMAD/GLI2 signaling axis in cancer progression and metastasis. Cancer Res 71: 5606-5610. doi: 10.1158/0008-5472.CAN-11-1194 PMID: 21862631
11. Deryugina EI, Quigley JP (2006) Matrix metalloproteinases and tumor metastasis. Cancer Metastasis Rev 25: 9-34. PMID: 16680569
12. Krstic J, Santibanez JF (2014) Transforming growth factor-beta and matrix metalloproteinases: functional interactions in tumor stroma-infiltrating myeloid cells. Scientific World Journal 2014: 521754. doi: 10.1155/2014/521754 PMID: 24578639
13. Wiercinska E, Naber HP, Pardali E, van der Pluijm G, van Dam H, et al. (2011) The TGF-beta/Smad pathway induces breast cancer cell invasion through the up-regulation of matrix metalloproteinase 2 and 9 in a spheroid invasion model system. Breast Cancer Res Treat 128: 657-666. doi: 10.1007/s10549-010-1147-x PMID: 20821046
14. Tang L, Han X (2013) The urokinase plasminogen activator system in breast cancer invasion and metastasis. Biomed Pharmacother 67: 179-182. doi: 10.1016/j.biopha.2012.10.003 PMID: 23201006
15. Chen Y, Shi HY, Stock SR, Stern PH, Zhang M (2011) Regulation of breast cancer-induced bone lesions by beta-catenin protein signaling. J Biol Chem 286: 42575-42584. doi: 10.1074/jbc.M111. 294595 PMID: 22009747
16. Verheyen EM, Gottardi CJ (2010) Regulation of Wnt/beta-catenin signaling by protein kinases. Dev Dyn 239: 34-44. doi: 10.1002/dvdy.22019 PMID: 19623618
17. Asuthkar S, Gondi CS, Nalla AK, Velpula KK, Gorantla B, et al. (2012) Urokinase-type plasminogen activator receptor (uPAR)-mediated regulation of WNT/beta-catenin signaling is enhanced in irradiated medulloblastoma cells. J Biol Chem 287: 20576-20589. doi: 10.1074/jbc.M112.348888 PMID: 22511755
18. Mukherjee N, Bhattacharya N, Alam N, Roy A, Roychoudhury S, et al. (2012) Subtype-specific alterations of the Wnt signaling pathway in breast cancer: clinical and prognostic significance. Cancer Sci 103: 210-220. doi: 10.1111/j.1349-7006.2011.02131.x PMID: 22026417
19. Sanchez-Tillo E, de Barrios O, Siles L, Cuatrecasas M, Castells A, et al. (2011) beta-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Proc Natl Acad Sci U S A 108: 19204-19209. doi: 10.1073/pnas.1108977108 PMID: 22080605
20. Walsh LA, Damjanovski S (2011) IGF-1 increases invasive potential of MCF 7 breast cancer cells and induces activation of latent TGF-beta1 resulting in epithelial to mesenchymal transition. Cell Commun Signal 9: 10. doi: 10.1186/1478-811X-9-10 PMID: 21535875
21. Ao ZH, Xu ZH, Lu ZM, Xu HY, Zhang XM, et al. (2009) Niuchangchih (Antrodia camphorata) and its potential in treating liver diseases. J Ethnopharmacol 121: 194-212. doi: 10.1016/j.jep.2008.10.039 PMID: 19061947
22. Lu MC, El-Shazly M, Wu TY, Du YC, Chang TT, et al. (2013) Recent research and development of Antrodia cinnamomea. Pharmacol Ther 139: 124-156. doi: 10.1016/j.pharmthera.2013.04.001 PMID: 23563277
23. Nakamura N, Hirakawa A, Gao JJ, Kakuda H, Shiro M, et al. (2004) Five new maleic and succinic acid derivatives from the mycelium of Antrodia camphorata and their cytotoxic effects on LLC tumor cell line. J Nat Prod 67: 46-48. PMID: 14738384
24. Wu MD, Cheng MJ, Wang BC, Yech YJ, Lai JT, et al. (2008) Maleimide and maleic anhydride derivatives from the mycelia of Antrodia cinnamomea and their nitric oxide inhibitory activities in macrophages. J Nat Prod 71: 1258-1261. doi: 10.1021/np070634k PMID: 18522430
25. Chien SC, Chen ML, Kuo HT, Tsai YC, Lin BF, et al. (2008) Anti-inflammatory activities of new succinic and maleic derivatives from the fruiting body of Antrodia camphorata. J Agric Food Chem 56: 7017-7022. doi: 10.1021/jf801171x PMID: 18642845
26. Zhang X, Li Y, Zhang Y, Song J, Wang Q, et al. (2013) Beta-elemene blocks epithelial-mesenchymal transition in human breast cancer cell line MCF-7 through Smad3-mediated down-regulation of nuclear transcription factors. PLoS One 8: e58719. doi: 10.1371/journal.pone.0058719 PMID: 23516540
27. Deryugina EI, Ratnikov B, Monosov E, Postnova TI, DiScipio R, et al. (2001) MT1-MMP initiates activation of pro-MMP-2 and integrin alphavbeta3 promotes maturation of MMP-2 in breast carcinoma cells. Exp Cell Res 263: 209-223. PMID: 11161720
28. Yang J, Weinberg RA (2008) Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 14: 818-829. doi: 10.1016/j.devcel.2008.05.009 PMID: 18539112
29. Lambrechts A, Van Troys M, Ampe C (2004) The actin cytoskeleton in normal and pathological cell motility. Int J Biochem Cell Biol 36: 1890-1909. PMID: 15203104
30. de Graauw M, van Miltenburg MH, Schmidt MK, Pont C, Lalai R, et al. (2010) Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A 107: 6340-6345. doi: 10.1073/pnas.0913360107 PMID: 20308542
31. Cheng JC, Auersperg N, Leung PC (2012) TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. PLoS One 7: e42436. doi: 10.1371/journal.pone.0042436 PMID: 22905131
32. Sundqvist A, Zieba A, Vasilaki E, Herrera Hidalgo C, Soderberg O, et al. (2013) Specific interactions between Smad proteins and AP-1 components determine TGFbeta-induced breast cancer cell invasion. Oncogene 32: 3606-3615. doi: 10.1038/onc.2012.370 PMID: 22926518
33. Caraci F, Gili E, Calafiore M, Failla M, La Rosa C, et al. (2008) TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts. Pharmacol Res 57: 274-282. doi: 10.1016/j.phrs.2008.02.001 PMID: 18346908